Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
The Journal of Antimicrobial Chemotherapy|October 3, 2002
Brain tissue penetration of ciprofloxacin following a single intravenous doseMarc Leone, Emmanuelle Sampol-Manos, Dominique Santelli, et al.
Cancer Chemotherapy and Pharmacology|October 5, 2011
Impact of plasma and intracellular exposure and CYP3A4, CYP3A5, and ABCB1 genetic polymorphisms on vincristine-induced neurotoxicityRomain Guilhaumou, Caroline Solas, Veronique Bourgarel-Rey, et al.
Pharmacogenomics|January 23, 2020
Pharmacogenetics and pharmacokinetics modeling of unexpected and extremely severe toxicities after sorafenib intakeHai le Ba, Litaty Mbatchi, Florence Gattacceca, et al.
Current Topics in Medicinal Chemistry|September 18, 2012
Population pharmacokinetic analysis of 5-FU and 5-FDHU in colorectal cancer patients: search for biomarkers associated with gastro-intestinal toxicityChristian Woloch, Antonello Di Paolo, Hafedh Marouani, et al.
Toxics|February 24, 2022
Determination of Prenatal Substance Exposure Using Meconium and Orbitrap Mass SpectrometryAtakan Hernandez, Valerie Lacroze, Natalia Doudka, et al.
Clinical Toxicology (Philadelphia, Pa.)|January 27, 2025
Presence of sibutramine and sildenafil in weight loss dietary supplements: a case series with analytical and clinical investigationMarie Carles, Tessa Pietri, Joelle Micallef, et al.
Clinical Cancer Drugs|April 24, 2018
UPFRONT DPD DEFICIENCY DETECTION TO SECURE 5-FU ADMINISTRATION: PART 2- APPLICATION TO HEAD-AND-NECK CANCER PATIENTSManon Launay, Joseph Ciccolini, Claire Fournel, et al.
Toxicology and Applied Pharmacology|February 23, 2002
Increase of CYP1B1 transcription in human keratinocytes and HaCaT cells after UV-B exposurePierre H Villard, Emmanuelle Sampol, Jean L Elkaim, et al.
Therapeutic Drug Monitoring|September 23, 2008
Population pharmacokinetics of atazanavir in human immunodeficiency virus-infected patientsCaroline Solas, Marie-Claude Gagnieu, Isabelle Ravaux, et al.
Pageof 9